Literature DB >> 33437394

Influence of variants of the drosha, mir499a, and mir938 genes on susceptibility to acute lymphoblastic leukemia in an admixed population from the brazilian amazon.

Tatiane Piedade de Souza1, Darlen Cardoso de Carvalho2, Alayde Viera Wanderley2,3, Sweny Marinho Fernandes2,3, Juliana Carla Gomes Rodrigues2, Amanda Cohen-Paes2, Marianne Rodrigues Fernandes2, Fernando Augusto Rodrigues Mello Junior4, Lucas Favacho Pastana2, Lui Wallacy Morikawa Souza Vinagre2, Artur Luiz da Costa Silva5, Paulo Pimentel de Assumpção2, Sidney Santos2,1, André Salim Khayat2, Ney Pereira Carneiro Dos Santos2,1.   

Abstract

Acute Lymphoblastic Leukemia (ALL) is the most common type of cancer in children. Polymorphisms that alter the normal function of the microRNAs involved in the development of ALL have been widely investigated, although published data on these polymorphisms in admixed populations are scarce. We investigated the role of 10 polymorphisms in the microRNA and protein-coding genes of the microRNA synthesis complex in susceptibility to pediatric B-cell ALL. The study includes 100 pediatric ALL patients and 180 healthy individuals. The statistical analyses were run in SPSS v.25.0. In the case of the microRNA synthesizing genes, a significant pattern was found in only gene, that is, the rs3805500 polymorphism of DROSHA, in which the homozygous mutant (AA) genotype was associated with a threefold increase in the risk of developing ALL when compared to other genotypes (P=0.004, OR=2.913, CI=1.415-5.998). In the microRNA coding genes, the homozygous mutant rs3746444 genotype of the MIR499A gene was associated with a 17-fold increase in the risk of development of ALL (P<0.001, OR=17.797, CI=5.55-57.016). A protective effect against the development of ALL was also observed in the carriers of the wild homozygous rs2505901 genotype in the MIR938 gene. Our findings highlight the potential of these polymorphisms in the genes involving in the coding of microRNAs for the evaluation of the risk of contracting ALL in the population of the Brazilian Amazon region. These findings contribute to a more complete understanding of the complex etiology of ALL. AJTR
Copyright © 2020.

Entities:  

Keywords:  Acute lymphoblastic leukemia; microRNAs; single nucleotide polymorphism; susceptibility

Year:  2020        PMID: 33437394      PMCID: PMC7791525     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  45 in total

Review 1.  Somatic and germline genomics in paediatric acute lymphoblastic leukaemia.

Authors:  Ching-Hon Pui; Kim E Nichols; Jun J Yang
Journal:  Nat Rev Clin Oncol       Date:  2019-04       Impact factor: 66.675

2.  Association of single nucleotide polymorphism in hsa-miR-499 and hsa-miR-196a2 with the risk of prostate cancer.

Authors:  Ramin Nouri; Saeid Ghorbian
Journal:  Int Urol Nephrol       Date:  2019-03-13       Impact factor: 2.370

3.  Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels.

Authors:  B Muralidhar; L D Goldstein; G Ng; D M Winder; R D Palmer; E L Gooding; N L Barbosa-Morais; G Mukherjee; N P Thorne; I Roberts; M R Pett; N Coleman
Journal:  J Pathol       Date:  2007-08       Impact factor: 7.996

4.  MicroRNA-499a decelerates glioma cell proliferation while accelerating apoptosis through the suppression of Notch1 and the MAPK signaling pathway.

Authors:  Bang-Qing Wang; Bin Yang; Hua-Chao Yang; Jun-Yi Wang; Sen Hu; Yu-Shuai Gao; Xing-Yao Bu
Journal:  Brain Res Bull       Date:  2018-06-15       Impact factor: 4.077

5.  International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years.

Authors:  Martha S Linet; Linda M Brown; Sam M Mbulaiteye; David Check; Evgenia Ostroumova; Annelie Landgren; Susan S Devesa
Journal:  Int J Cancer       Date:  2015-12-21       Impact factor: 7.396

6.  The rs61764370 Functional Variant in the KRAS Oncogene is Associated with Chronic Myeloid Leukemia Risk in Women.

Authors:  Humberto Gutiérrez-Malacatt; Manuel Ayala-Sanchez; Xochitl Aquino-Ortega; Jacqueline Dominguez-Rodriguez; Adolfo Martinez-Tovar; Irma Olarte-Carrillo; Angelica Martinez-Hernandez; Cecilia Contreras-Cubas C; Lorena Orozco; Emilio J Cordova
Journal:  Asian Pac J Cancer Prev       Date:  2016

7.  Association of microRNA-499 rs3746444 polymorphism with cancer risk: evidence from 7188 cases and 8548 controls.

Authors:  Fang Wang; Guoping Sun; Yanfeng Zou; Yuanyuan Li; Li Hao; Faming Pan
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

8.  Genetic variants in miRNA processing genes and pre-miRNAs are associated with the risk of chronic lymphocytic leukemia.

Authors:  Idoia Martin-Guerrero; Angela Gutierrez-Camino; Elixabet Lopez-Lopez; Nerea Bilbao-Aldaiturriaga; Maria Pombar-Gomez; Maite Ardanaz; Africa Garcia-Orad
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

9.  Predictive Value of MiR-219-1, MiR-938, MiR-34b/c, and MiR-218 Polymorphisms for Gastric Cancer Susceptibility and Prognosis.

Authors:  Yanhua Wu; Zhifang Jia; Donghui Cao; Chuan Wang; Xing Wu; Lili You; Simin Wen; Yuchen Pan; Xueyuan Cao; Jing Jiang
Journal:  Dis Markers       Date:  2017-02-19       Impact factor: 3.434

10.  The role of microRNA-608 polymorphism on the susceptibility and survival of cancer: a meta-analysis.

Authors:  Zhi-Ming Dai; Jian-Rui Lv; Kang Liu; Xiao-Ming Lei; Wei Li; Gang Wu; Xing-Han Liu; Yu-Xiao Zhu; Qian Hao; Zhi-Jun Dai
Journal:  Aging (Albany NY)       Date:  2018-06-16       Impact factor: 5.682

View more
  3 in total

1.  Association Analysis Between the Functional Single Nucleotide Variants in miR-146a, miR-196a-2, miR-499a, and miR-612 With Acute Lymphoblastic Leukemia.

Authors:  Silvia Jiménez-Morales; Juan Carlos Núñez-Enríquez; Jazmín Cruz-Islas; Vilma Carolina Bekker-Méndez; Elva Jiménez-Hernández; Aurora Medina-Sanson; Irma Olarte-Carrillo; Adolfo Martínez-Tovar; Janet Flores-Lujano; Julian Ramírez-Bello; María Luisa Pérez-Saldívar; Jorge Alfonso Martín-Trejo; Héctor Pérez-Lorenzana; Raquel Amador-Sánchez; Felix Gustavo Mora-Ríos; José Gabriel Peñaloza-González; David Aldebarán Duarte-Rodríguez; José Refugio Torres-Nava; Juan Eduardo Flores-Bautista; Rosa Martha Espinosa-Elizondo; Pedro Francisco Román-Zepeda; Luz Victoria Flores-Villegas; Edna Liliana Tamez-Gómez; Víctor Hugo López-García; José Ramón Lara-Ramos; Juana Esther González-Ulivarri; Sofía Irene Martínez-Silva; Gilberto Espinoza-Anrubio; Carolina Almeida-Hernández; Rosario Ramírez-Colorado; Luis Hernández-Mora; Luis Ramiro García-López; Gabriela Adriana Cruz-Ojeda; Arturo Emilio Godoy-Esquivel; Iris Contreras-Hernández; Abraham Medina-Hernández; María Guadalupe López-Caballero; Norma Angélica Hernández-Pineda; Jorge Granados-Kraulles; María Adriana Rodríguez-Vázquez; Delfino Torres-Valle; Carlos Cortés-Reyes; Francisco Medrano-López; Jessica Arleet Pérez-Gómez; Annel Martínez-Ríos; Antonio Aguilar-De-Los-Santos; Berenice Serafin-Díaz; María de Lourdes Gutiérrez-Rivera; Laura Elizabeth Merino-Pasaye; Gilberto Vargas-Alarcón; Minerva Mata-Rocha; Omar Alejandro Sepúlveda-Robles; Haydeé Rosas-Vargas; Alfredo Hidalgo-Miranda; Juan Manuel Mejía-Aranguré
Journal:  Front Oncol       Date:  2021-11-05       Impact factor: 6.244

2.  Genetic Variants of MicroRNA and DROSHA Genes in Association With the Risk of Tuberculosis in the Amazon Population.

Authors:  Diana Feio da Veiga Borges Leal; Mayara Natália Santana da Silva; Lucas Favacho Pastana; Marianne Rodrigues Fernandes; Aidalucy do Socorro Costa de Athayde; Débora Christina Ricardo Fernandes Porchera; Cleonardo Augusto da Silva; Antônio André Conde Modesto; Paulo Pimentel De Assumpcão; Sidney Emanuel Batista Dos Santos; Ney Pereira Carneiro Dos Santos
Journal:  Front Genet       Date:  2022-03-02       Impact factor: 4.599

Review 3.  MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools.

Authors:  Ioannis Kyriakidis; Konstantinos Kyriakidis; Aspasia Tsezou
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.